Analytical Data
-
Gene name
C17orf75
- Application
-
Alternative Names
NJMU-R1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HAS0
-
Expression Region
Met1~Phe396
-
Molecular Weight
50kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C17orf75, also known as Chromosome 17 Open Reading Frame 75, is a relatively understudied protein that has garnered interest due to its potential roles in cellular processes. Initial studies suggest that C17orf75 is involved in various biological functions, potentially including cell cycle regulation and apoptosis, although its exact mechanisms are not fully understood. As a protein encoded by a gene located on chromosome 17, its relevance is underscored by the fact that this chromosomal region is often implicated in various diseases, including cancers and genetic disorders. Recent advances in genomic and proteomic technologies have facilitated the exploration of C17orf75's structural properties and functional interactions. Researchers are keen to examine its expression patterns in different tissues and under various physiological and pathological conditions to elucidate its biological significance. Moreover, generating recombinant C17orf75 protein could provide insights into its functional domains and interactions with other cellular components. This line of research not only aims to delineate the role of C17orf75 in health and disease but may also pave the way for potential therapeutic applications, exploiting its biological properties for targeted interventions in related disorders. Overall, the study of C17orf75 serves as a promising avenue for understanding complex cellular mechanisms and identifying novel biomarkers or therapeutic targets.
